SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Pedersen T. R.)
 

Search: WFRF:(Pedersen T. R.) > Chalmers University of Technology > Microbiome and meta...

Microbiome and metabolome features of the cardiometabolic disease spectrum

Fromentin, S. (author)
Université Paris-Saclay,University Paris-Saclay
Forslund, S. K. (author)
European Molecular Biology Laboratory,Charité Universitätsmedizin Berlin,Charité University Medicine Berlin,Max Delbrueck Centrum Fuer Molekulare Medizin,The Max Delbrück Center for Molecular Medicine
Chechi, K. (author)
St Mary's Hospital
show more...
Aron-Wisnewsky, J. (author)
Sorbonne Université,Sorbonne University,Assistance publique – Hôpitaux de Paris (AP-HP)
Chakaroun, R. (author)
Universität Leipzig,Leipzig University
Nielsen, T. (author)
Köpenhamns universitet,University of Copenhagen
Tremaroli, Valentina, 1978 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory
Ji, Boyang, 1983 (author)
Chalmers tekniska högskola,Chalmers University of Technology
Prifti, E. (author)
Sorbonne Université,Sorbonne University,UMMISCO
Myridakis, A. (author)
Chilloux, J. (author)
Andrikopoulos, P. (author)
Fan, Y. (author)
Köpenhamns universitet,University of Copenhagen
Olanipekun, M. T. (author)
Alves, R. (author)
European Molecular Biology Laboratory
Adiouch, S. (author)
Sorbonne Université,Sorbonne University
Nielsen, Jens B, 1962 (author)
Weizmann Institute of Science,Köpenhamns universitet,University of Copenhagen,Chalmers tekniska högskola,Chalmers University of Technology
Talmor-Barkan, Y. (author)
Weizmann Institute of Science
Belda, E. (author)
Assistance publique – Hôpitaux de Paris (AP-HP),Sorbonne Université,Sorbonne University
Caesar, Robert, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory
Li, Peishun, 1988 (author)
European Molecular Biology Laboratory,Chalmers tekniska högskola,Chalmers University of Technology
Falony, G. (author)
Flanders Interuniversity Institute for Biotechnology,Katholieke Universiteit Leuven
Fellahi, S. (author)
Galan, P. (author)
Université Paris-Saclay,University Paris-Saclay
Galleron, N. (author)
Université Paris-Saclay,University Paris-Saclay
Helft, G. (author)
Assistance publique – Hôpitaux de Paris (AP-HP)
Hoyles, L. (author)
Nottingham Trent University
Isnard, R. (author)
Assistance publique – Hôpitaux de Paris (AP-HP)
Le Chatelier, E. (author)
Université Paris-Saclay,University Paris-Saclay
Julienne, H. (author)
Université Paris-Saclay,University Paris-Saclay
Olsson, Lisa M., 1984 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory
Pedersen, H. K. (author)
Köpenhamns universitet,University of Copenhagen
Pons, N. (author)
Université Paris-Saclay,University Paris-Saclay
Quinquis, B. (author)
Université Paris-Saclay,University Paris-Saclay
Rouault, C. (author)
Sorbonne Université,Sorbonne University
Roume, H. (author)
Université Paris-Saclay,University Paris-Saclay
Salem, J. E. (author)
Sorbonne Université,Sorbonne University
Schmidt, T. S. B. (author)
European Molecular Biology Laboratory
Vieira-Silva, S. (author)
Katholieke Universiteit Leuven,Flanders Interuniversity Institute for Biotechnology
Li, P. S. (author)
Zimmermann-Kogadeeva, M. (author)
European Molecular Biology Laboratory
Lewinter, C. (author)
Köpenhamns universitet,University of Copenhagen
Sondertoft, N. B. (author)
Hansen, T. H. (author)
Köpenhamns universitet,University of Copenhagen
Gauguier, D. (author)
Gotze, J. P. (author)
Köpenhamns universitet,University of Copenhagen
Kober, L. (author)
Köpenhamns universitet,University of Copenhagen
Kornowski, R. (author)
Vestergaard, H. (author)
Köpenhamns universitet,University of Copenhagen
Hansen, T. (author)
Zucker, J. D. (author)
UMMISCO,Sorbonne Université,Sorbonne University
Hercberg, S. (author)
Letunic, I. (author)
Biobyte Solutions GmbH
Bäckhed, Fredrik, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory,Köpenhamns universitet,University of Copenhagen
Oppert, J. M. (author)
Assistance publique – Hôpitaux de Paris (AP-HP)
Nielsen, J. (author)
Raes, J. (author)
Flanders Interuniversity Institute for Biotechnology,Katholieke Universiteit Leuven
Bork, P. (author)
European Molecular Biology Laboratory,Köpenhamns universitet,University of Copenhagen
Stumvoll, M. (author)
Universität Leipzig,Leipzig University
Segal, E. (author)
Weizmann Institute of Science
Clement, K. (author)
Sorbonne Université,Sorbonne University,Assistance publique – Hôpitaux de Paris (AP-HP)
Dumas, M. E. (author)
Ehrlich, S. D. (author)
Université Paris-Saclay,University Paris-Saclay,University College London (UCL)
Pedersen, O. (author)
show less...
 (creator_code:org_t)
2022-02-17
2022
English.
In: Nature Medicine. - : Springer Science and Business Media LLC. - 1078-8956 .- 1546-170X. ; 28:2
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • By studying individuals along a spectrum of cardiometabolic disease and adjusting for effects of lifestyle and medication, this investigation identifies alterations of the metabolome and microbiome from dysmetabolic conditions, such as obesity and type 2 diabetes, to ischemic heart disease. Previous microbiome and metabolome analyses exploring non-communicable diseases have paid scant attention to major confounders of study outcomes, such as common, pre-morbid and co-morbid conditions, or polypharmacy. Here, in the context of ischemic heart disease (IHD), we used a study design that recapitulates disease initiation, escalation and response to treatment over time, mirroring a longitudinal study that would otherwise be difficult to perform given the protracted nature of IHD pathogenesis. We recruited 1,241 middle-aged Europeans, including healthy individuals, individuals with dysmetabolic morbidities (obesity and type 2 diabetes) but lacking overt IHD diagnosis and individuals with IHD at three distinct clinical stages-acute coronary syndrome, chronic IHD and IHD with heart failure-and characterized their phenome, gut metagenome and serum and urine metabolome. We found that about 75% of microbiome and metabolome features that distinguish individuals with IHD from healthy individuals after adjustment for effects of medication and lifestyle are present in individuals exhibiting dysmetabolism, suggesting that major alterations of the gut microbiome and metabolome might begin long before clinical onset of IHD. We further categorized microbiome and metabolome signatures related to prodromal dysmetabolism, specific to IHD in general or to each of its three subtypes or related to escalation or de-escalation of IHD. Discriminant analysis based on specific IHD microbiome and metabolome features could better differentiate individuals with IHD from healthy individuals or metabolically matched individuals as compared to the conventional risk markers, pointing to a pathophysiological relevance of these features.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Biomedicinsk laboratorievetenskap/teknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Biomedical Laboratory Science/Technology (hsv//eng)

Keyword

coronary-artery-disease
gut microbiota
p-cresol
heart
risk
impact
serum
signatures
plasma
health
Biochemistry & Molecular Biology
Cell Biology
Research & Experimental
Medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view